Evidence map›Paper›PMID 28459101›Full record

ArticleLaryngoscope investigative otolaryngology2016

Innate immunity and chronic rhinosinusitis: What we have learned from animal models.

Nyall R London, Andrew P Lane

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05365841 (Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05365841 unknown statusnot on this mapstarted 2022, after this paper: background citation

Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Can Shedding of Epithelial Barrier Proteins be Used as Biomarker in Severe Asthma With/Out CRSwNP Management?

TypeobservationalSponsorUniversity of CreteRan2022 to 2025Enrolled85ConditionsSevere Eosinophilic Asthma w/wo CRSwNPArmsMepolizumab 100 MG
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epithelial barriers in allergy and asthma.The Journal of allergy and clinical immunology · 2020
    Review
  5. The Microbiome and Chronic Rhinosinusitis.Immunology and allergy clinics of North America · 2020
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sinuses and Common Rhinologic Conditions.The Medical clinics of North America · 2018
    Review
  12. Aeroallergens, air pollutants, and chronic rhinitis and rhinosinusitis.World journal of otorhinolaryngology - head and neck surgery · 2018
    Review
  13. Impact of odontogenic chronic rhinosinusitis on general health-related quality of life.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Article
  14. Article
  15. Article
  16. The Role of the Sinonasal Epithelium in Allergic Rhinitis.Otolaryngologic clinics of North America · 2017
    Review
  17. Airborne Particulate Matter Induces Nonallergic Eosinophilic Sinonasal Inflammation in Mice.American journal of respiratory cell and molecular biology · 2017
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nyall R LondonJohns Hopkins Department of Otolaryngology - Head and Neck Surgery, Baltimore, MD.
Andrew P LaneJohns Hopkins Department of Otolaryngology - Head and Neck Surgery, Baltimore, MD.
Johns Hopkins University · US

Funding

Immune Responses of the Epithelium in Chronic Rhinosinusitis with PolypsR01AI072502 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LANE, ANDREW P · 2007 to 2016
$3.9M
The Role of ARNO-Arf6 signaling in barrier stability and chronic rhinosinusitisR21AI119547 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LANE, ANDREW P · 2015 to 2016
$446k
NIAID NIH HHS R01 AI072502NIAID NIH HHS R21 AI119547
6 · The paper itself

Abstract

objectiveChronic rhinosinusitis (CRS) is a heterogeneous and multifactorial disease characterized by dysregulated inflammation. Abnormalities in innate immune function including sinonasal epithelial cell barrier function, mucociliary clearance, response to pathogen-associated molecular patterns (PAMPs) via pattern recognition receptors (PRRs), and the contribution of innate immune cells will be highlighted in this review. DATA SOURCES: PubMed literature review. REVIEW

methodsA review of the literature was conducted to determine what we have learned from animal models in relation to innate immunity and chronic rhinosinusitis.

resultsDysregulation of innate immune mechanisms including sinonasal barrier function, mucociliary clearance, PAMPs, and innate immune cells such as eosinophils, mast cells, and innate lymphoid cells may contribute to CRS pathogenesis. Sinonasal inflammation has been studied using mouse, rat, rabbit, pig, and sheep explant or

conclusionAnimal models have shed light as to the potential contribution of dysregulated innate immunity in chronic sinonasal inflammation.

Identifiers

PMID28459101
PMCPMC5409101
OpenAlexW2418208650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.